Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals

被引:0
|
作者
Maryam H. Alrashid
Ahmad Al-Serri
Salem H. Alshemmari
Philip Koshi
Suzanne A. Al-Bustan
机构
[1] Kuwait University,Department of Biological Sciences, Faculty of Science
[2] Kuwait University,Department of Pathology, Faculty of Medicine
[3] Kuwait University,Department of Medicine, Faculty of Medicine
来源
关键词
Warfarin; International Normalization Ratio; Single Nucleotide Polymorphism; Warfarin Dose; Warfarin Dose Requirement;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:183 / 190
页数:7
相关论文
共 50 条
  • [1] Association of Genetic Polymorphisms in the VKORC1 and CYP2C9 Genes with Warfarin Dosage in a Group of Kuwaiti Individuals
    Alrashid, Maryam H.
    Al-Serri, Ahmad
    Alshemmari, Salem H.
    Koshi, Philip
    Al-Bustan, Suzanne A.
    MOLECULAR DIAGNOSIS & THERAPY, 2016, 20 (02) : 183 - 190
  • [2] Dependency of phenprocoumon dosage on polymorphisms in the VKORC1 and CYP2C9 genes
    Qazim, Berisha
    Stoellberger, Claudia
    Krugluger, Walter
    Dossenbach-Glaninger, Astrid
    Finsterer, Josef
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 28 (02) : 211 - 214
  • [3] Dependency of phenprocoumon dosage on polymorphisms in the VKORC1 and CYP2C9 genes
    Berisha Qazim
    Claudia Stöllberger
    Walter Krugluger
    Astrid Dossenbach-Glaninger
    Josef Finsterer
    Journal of Thrombosis and Thrombolysis, 2009, 28 : 211 - 214
  • [4] Warfarin sensitivity and CYP2C9 and VKORC1 genes
    Bukaveckas, Bonny Lewis
    INFLAMMATION RESEARCH, 2007, 56 : S223 - S224
  • [5] Association between polymorphisms of the VKORC1 and CYP2C9 genes and warfarin maintenance dose in Peruvian patients
    Oscanoa, Teodoro J.
    Guevara-Fujita, Maria L.
    Fujita, Ricardo M.
    Munoz-Paredes, Maria Y.
    Acosta, Oscar
    Romero-Ortuno, Roman
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (03) : 769 - 775
  • [6] Association between polymorphisms of VKORC1 and CYP2C9 genes with warfarin maintenance dose in a group of warfarin users in Birjand city, Iran
    Fereidouni, Mohammad
    Moossavi, Maryam
    Kazemi, Touba
    Nouranihassankiade, Shaghayeghsadat
    Asghari, Arghavan
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (06) : 9588 - 9593
  • [7] VKORC1 and CYP2C9 polymorphisms predict warfarin dosage in a large anticoagulant clinic cohort
    Fu, L.
    Selby, R.
    Shuen, A.
    Wong, B.
    Cole, D. E. C.
    CLINICAL BIOCHEMISTRY, 2006, 39 (11) : 1094 - 1094
  • [8] Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients
    Zhang, Suli
    Zhao, Mingzhe
    Zhong, Shilong
    Niu, Jiamin
    Zhou, Lijuan
    Zhu, Bin
    Su, Haili
    Cao, Wei
    Xing, Qinghe
    Yan, Hongli
    Han, Xia
    Fu, Qihua
    Li, Qiang
    Chen, Luan
    Yang, Fan
    Zhang, Na
    Wu, Hao
    He, Lin
    Qin, Shengying
    PHARMACOGENETICS AND GENOMICS, 2024, 34 (04): : 105 - 116
  • [9] Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients
    Taisei Mushiroda
    Yozo Ohnishi
    Susumu Saito
    Atsushi Takahashi
    Yuka Kikuchi
    Shigeru Saito
    Hideki Shimomura
    Yasuhiko Wanibuchi
    Takao Suzuki
    Naoyuki Kamatani
    Yusuke Nakamura
    Journal of Human Genetics, 2006, 51 : 249 - 253
  • [10] Association of VKORC1 and CYP2C9 polymorphisms with warfarin dose requirements in Japanese patients
    Mushiroda, T
    Ohnishi, Y
    Saito, S
    Takahashi, A
    Kikuchi, Y
    Saito, S
    Shimomura, H
    Wanibuchi, Y
    Suzuki, T
    Kamatani, N
    Nakamura, Y
    JOURNAL OF HUMAN GENETICS, 2006, 51 (03) : 249 - 253